Results 131 to 140 of about 1,251,059 (351)

ESMO/ASCO Recommendations for a Global Curriculum in Medical Oncology Edition 2023. [PDF]

open access: yesESMO Open, 2023
Cufer T   +2 more
europepmc   +2 more sources

Simultaneous inhibition of TRIM24 and TRIM28 sensitises prostate cancer cells to antiandrogen therapy, decreasing VEGF signalling and angiogenesis

open access: yesMolecular Oncology, EarlyView.
TRIM24 and TRIM28 are androgen receptor (AR) coregulators which exhibit increased expression with cancer progression. Both TRIM24 and TRIM28 combine to influence the response of castrate‐resistant prostate cancer (CRPC) cells to AR inhibitors by mediating AR signalling, regulation of MYC and upregulating VEGF to promote angiogenesis. Castrate‐resistant
Damien A. Leach   +8 more
wiley   +1 more source

Understanding facilitators and barriers to contraception screening and referral in young women with cancer [PDF]

open access: yes, 2018
BACKGROUND: Young women with cancer often worry about impaired fertility after treatment but can experience devastating consequences from an unplanned pregnancy during treatment. Contraception screening and referral appear to occur infrequently in cancer
Lindsay, Sarah
core  

The Medical Case for a Positron Emission Tomography and X-ray Computed Tomography Combined Service in Oman

open access: yesSultan Qaboos University Medical Journal, 2013
The value of a positron emission tomography and X-ray computed tomography (PET/CT) combined service in terms of diagnostic accuracy, cost-effectiveness and impact on clinical decision-making is welldocumented in the literature. Its role in the management
Naima K. Al-Bulushi   +2 more
doaj  

Identifying associations between sample characteristics, symptoms, and self‐efficacy differences in adult patients with rare tumors of the central nervous system who participated in a novel web‐based natural history study

open access: yesCancer Medicine
Objective High self‐efficacy is associated with improved self‐care and reduced symptoms in cancer patients but has not been fully interrogated in adults with central nervous system (CNS) cancers.
Alvina Acquaye‐Mallory   +5 more
doaj   +1 more source

EMT‐associated bias in the Parsortix® system observed with pancreatic cancer cell lines

open access: yesMolecular Oncology, EarlyView.
The Parsortix® system was tested for CTC enrichment using pancreatic cancer cell lines with different EMT phenotypes. Spike‐in experiments showed lower recovery of mesenchymal‐like cells. This was confirmed with an EMT‐inducible breast cancer cell line.
Nele Vandenbussche   +8 more
wiley   +1 more source

Association between physician characteristics and payments from industry in 2015-2017: observational study. [PDF]

open access: yes, 2019
OBJECTIVE:To investigate the association between physician characteristics and the value of industry payments. DESIGN:Observational study. SETTING AND PARTICIPANTS:Using the 2015-2017 Open Payments reports of industry payments linked to the Physician ...
Blumenthal, Daniel M   +3 more
core  

Tumor clusters with divergent inflammation and human retroelement expression determine the clinical outcome of patients with serous ovarian cancer

open access: yesMolecular Oncology, EarlyView.
Analysis of treatment‐naïve high‐grade serous ovarian carcinoma (HGSOC) and control tissues for ERVs, LINE‐1 (L1), inflammation, and immune checkpoints identified five clusters with diverse patient recurrence‐free survivals. An inflammation score was calculated and correlated with retroelement expression, where one novel cluster (Triple‐I) with high ...
Laura Glossner   +6 more
wiley   +1 more source

Major Advances in the Treatment of Cancer What does a Non-Oncologist need to know?

open access: yesSultan Qaboos University Medical Journal, 2008
The last few years have seen major advances in the management of cancers. Since it is not possible for the non-oncologist to keep abreast with the latest developments in the field of oncology, this review summarises the most significant advances in the ...
Ikram A Burney, Mansour S Al-Moundhri
doaj  

Home - About - Disclaimer - Privacy